metformin has been researched along with srt1720 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Apetoh, L; Berger, H; Boidot, R; Chalons, P; Delmas, D; Derangère, V; Euvrard, R; Ghiringhelli, F; Humblin, E; Ladoire, S; Limagne, E; Rébé, C; Thibaudin, M; Végan, F | 1 |
| Abulwerdi, G; Bernier, M; de Cabo, R; Elliott, P; Ellis, JL; Licata, JJ; Minor, RK; Mitchell, SJ; Palacios, HH; Palliyaguru, DL; Price, NL; Sinclair, DA; Ward, TM; Westphal, C | 1 |
3 other study(ies) available for metformin and srt1720
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation.
Topics: Acetylation; Animals; Carbazoles; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Heterocyclic Compounds, 4 or More Rings; Humans; Melanoma, Experimental; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 3; Sirtuin 1; STAT3 Transcription Factor; Th17 Cells; Transplantation, Heterologous | 2017 |
Combining a High Dose of Metformin With the SIRT1 Activator, SRT1720, Reduces Life Span in Aged Mice Fed a High-Fat Diet.
Topics: Animals; Body Composition; Body Weight; Diet, High-Fat; Heterocyclic Compounds, 4 or More Rings; Longevity; Male; Metformin; Mice; Mice, Inbred C57BL; Models, Animal; Sirtuin 1 | 2020 |